ADVM Adverum Biotechnologies Inc.: Company Net Assets
The asset value of Adverum Biotechnologies (ADVM) tracked on this chart stands at -0.06. The business relies on external contractors for testing and vector production. Due to the absence of commercial products, research costs are creating negative operating leverage. Meanwhile, Adverum Biotechnologies (ADVM) acts as a bioengineering pioneer, developing single-injection therapies to restore vision in cases of genetic pathologies.
ADVM (Adverum): analytical breakdowns and indicator data
Book value determines the residual value of net assets minus all liabilities, reflecting the shareholders' actual internal resources. This metric allows for an assessment of the financial resilience of Adverum Biotechnologies (ADVM) against supply chain disruptions and patent risks, making the company's balance sheet equity history a critical tool for avoiding overpayment for the asset.